Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: A systematic review

Cerebrovascular Diseases

Volumn 33, Issue 1, 2012, Pages 47-54

  Ahmad, Omar ^a   Wardlaw, Joanna ^a   Whiteley, William N ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Blood biomarkers; Infarct volume; Ischaemic stroke

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S100B;

AREA UNDER THE CURVE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DATA BASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIA CELL; HUMAN; MEDICAL LITERATURE; MEDLINE; NERVE CELL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REVIEW; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK;

BIOLOGICAL MARKERS; BRAIN; BRAIN ISCHEMIA; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MAGNETIC RESONANCE IMAGING; MYELIN BASIC PROTEINS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; S100 PROTEINS; STROKE; TAU PROTEINS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82355164323     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000332810     Document Type: Review

References (31)

1. Atkinson AJ, Colburn WA, DeGruttola VG, et al: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95. (Pubitemid 32225406)
2. Dassan P, Keir G, Brown MM: Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 2009; 27: 295-302.
3. Whiteley W, Chong WL, Sengupta A, Sandercock P: Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009; 40:e380-e389.
4. Kirkwood BR, Sterne JAC: Essential Medical Statistics. Oxford, Blackwell, 2003.
5. Field AP: Meta-analysis of correlation coefficients: a Monte Carlo comparison of fixedand random-effects methods. Psychol Methods 2001; 6: 161-180. (Pubitemid 33604037)
6. Foerch C, du Mesnil de RR, Singer O, et al: S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery cclusion. J Neurol Neurosurg Psychiatry 2003; 74: 322-325. (Pubitemid 36259355)
7. Foerch C, Otto B, Singer OC, et al: Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke 2004; 35: 2160-2164. (Pubitemid 39129579)
8. Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de RR, Steinmetz H, Sitzer M: Evaluation of serum S100B as a surrogate arker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005; 62: 1130-1134. (Pubitemid 41043736)
9. Geiger S, Holdenrieder S, Stieber P, et al: Nucleosomes as a new prognostic marker in early cerebral stroke. J Neurol 2007; 254: 623.
10. Herrmann M, Vos P, Wunderlich MT, de Bruijn CHMM, Lamers KJB: Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000; 31: 2670-2677.
11. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M: Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30: 1190-1195. (Pubitemid 29259172)
12. Cunningham RT, Watt M, Winder J, et al: Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest 1996; 26: 298-303. (Pubitemid 26147065)
13. Rivers CS, Wardlaw JM: What has diffusion maging in animals told us about diffusion imaging in patients with ischaemic stroke?Cerebrovasc Dis 2005; 19: 328-336. (Pubitemid 40663310)
14. Guzel A, Er U, Tatli M, et al: Serum neuronspecific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury. Neurosurg Rev 2008; 31: 439-444.
15. Meric E, Gunduz A, Turedi S, Cakir E, Yandi M: The prognostic value of neuron-specific enolase in head trauma patients. J Emerg Med 2010; 38: 297-301.
16. Vos PE, Jacobs B, Andriessen TM, et al: GFAP and S100B are biomarkers of traumatic rain injury: an observational cohort study. Neurology 2010; 75: 1786-1793.
17. Egger M, Smith GD: Bias in location and selection of studies. BMJ 1998; 316: 61-66.
18. Jauch EC, Lindsell C, Broderick J, et al: Association of serial biochemical markers with cute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006; 37: 2508-2513. (Pubitemid 44454670)
19. Saver JL, Johnston KC, Homer D, et al: Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke 1999; 30: 293-298. (Pubitemid 29071792)
20. Hand PJ, Wardlaw JM, Rivers CS, et al: MR diffusion-weighted imaging and outcome prediction after ischemic stroke. Neurology 2006; 66: 1159-1163. (Pubitemid 43739696)
21. Johnston KC, Barrett KM, Ding YH, Wagner DP; for the ASAP Investigators: Clinical and imaging data at 5 days as a surrogate for 90-day outcome in ischemic stroke. Stroke 2009; 40: 1332-1333.
22. Wardlaw JM: Surrogate outcomes: a cautionary note. Stroke 2009; 40: 1029-1031.
23. Brea D, Sobrino T, Blanco M, et al: Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med 2009; 47: 1513-1518.
24. Oh SH, Lee JG, Na SJ, Park JH, Choi YC, Kim WJ: Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level. Arch Neurol 2003; 60: 37-41.
25. Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M: Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg 006; 108: 558-563. (Pubitemid 44189097)
26. Wunderlich MT, Wallesch CW, Goertler M: Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol 2006; 13: 1118-1123. (Pubitemid 44434318)
27. Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of nfarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28: 1956-1960. (Pubitemid 27459003)
28. Wu YC, Zhao YB, Lu CZ, Qiao J, Tan YJ: Correlation between serum level of neuron-specific enolase and long-term functional outcome fter acute cerebral infarction: prospective study. Hong Kong Med J 2004; 10: 251-254. (Pubitemid 39056150)
29. Wunderlich MT, Wallesch CW, Goertler M: Release of neurobiochemical markers of brain damage is related to the neurovascularstatus on admission and the site of arterial occlusion in acute ischemic stroke. J Neurol Sci 2004; 227: 49-53. (Pubitemid 39491125)
30. Bitsch A, Horn C, Kemmling Y, et al: Serum au protein level as a marker of axonal damage in acute ischemic stroke. Eur Neurol 2002; 47: 45-51.
31. Cunningham RT, Young IS, Winder J, O'Kane MJ, McKinstry S, Johnston CF, Dolan OM, Hawkins SA, Buchanan KD: Serum neurone specific enolase (NSE) as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991; 21: 497-500.